KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int. 2022;102(5S):S1-S127.
Leggi
Verde
Le Breaking News di colore verde sono relative a linee-guida, consensus, statement ecc.
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies MJ, Aroda VR, Collins BS et al.
Diabetologia. Pub. online 24 September 2022.
Leggi
Management of heart failure
Belkin MN, Cifu AS, Pinney S
JAMA. Pub. Online 15 Sep 2022.
Leggi
Screening for prediabetes and type 2 diabetes in children and adolescents – us preventive services task force recommendation statement
Mangione CM, Barry MJ, Nicholson WK, et al.
JAMA. 2022;328(10):963-967.
Leggi
Important Updates to the Standards of Medical Care in Diabetes—2022 Incorporate New Evidence:
Diabetes Care. 2022;45(Suppl. 1):S144–S174.
Diabetes Care. 2022;45(Suppl. 1):S175–S184.
Leggi
Linea Guida della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP)
La terapia del diabete mellito di tipo 1
Leggi
Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association
Joseph JJ, Deedwania P, Acharya T, et al.
Circulation. 2022;0:CIR.0000000000001040
Leggi
Italian guidelines for the treatment of type 2 diabetes
Mannucci E, Candido R, delle Monache L, Gallo M, Giaccari A, Masini ML, Mazzone A, Medea G, Pintaudi B, Targher G, Trento M, Turchetti G, Lorenzoni V, Monami M
NMCD. Pub. online 3 Febbraio 2022.
Leggi
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper.
Natalicchio A, Faggiano A, Zatelli MC, Argentiero A, D’Oronzo S, Marrano N, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Ferrari P, Gori S, Morviducci L, Russo A, Tuveri E, Montagnani M, Gallo M, Silvestris N, Giorgino F
Crit Rev Oncol Hematol. 2022;169:103572.
Leggi
Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association
Joseph JJ, Deedwania P, Acharya T, et al.
Circulation. 2022;CIR0000000000001040
Leggi